Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kaltenbach

Showing results (491-500 of 495) with videos related to

Pageof 50
Sort By:
You have reached the last page of results.This site can display upto 495 results.
Arquivos Brasileiros De Cardiologia|September 1, 1988
[Report on the meeting of the International Society and Federation of Cardiology and World Health Organization: task-force on coronary angioplasty]M G Bourassa, E L Alderman, M Bertrand, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|November 7, 2007
Geographical variation in populations of Phlebotomus (Paraphlebotomus) caucasicus (Diptera: Psychodidae) in IranV Moin-Vaziri, J Depaquit, M R Yaghoobi-Ershadi, et al.
Zeitschrift Fur Kardiologie|August 1, 1997
[Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study]M B Preisack, R Baildon, V Eschenfelder, et al.
World Journal of Gastroenterology|November 26, 2015
Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification-ultrasoundWolfgang Kratzer, Beate Gruener, Tanja E M Kaltenbach, et al.
Journal of the American College of Cardiology|November 15, 1996
Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled EvaluationK R Karsch, M B Preisack, R Baildon, et al.
Pageof 50

Showing results (491-500 of 495) with videos related to

Sort By:
Pageof 50
You have reached the last page of results.This site can display upto 495 results.
Arquivos Brasileiros De Cardiologia|September 1, 1988
[Report on the meeting of the International Society and Federation of Cardiology and World Health Organization: task-force on coronary angioplasty]M G Bourassa, E L Alderman, M Bertrand, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|November 7, 2007
Geographical variation in populations of Phlebotomus (Paraphlebotomus) caucasicus (Diptera: Psychodidae) in IranV Moin-Vaziri, J Depaquit, M R Yaghoobi-Ershadi, et al.
Zeitschrift Fur Kardiologie|August 1, 1997
[Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study]M B Preisack, R Baildon, V Eschenfelder, et al.
World Journal of Gastroenterology|November 26, 2015
Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis Ulm classification-ultrasoundWolfgang Kratzer, Beate Gruener, Tanja E M Kaltenbach, et al.
Journal of the American College of Cardiology|November 15, 1996
Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled EvaluationK R Karsch, M B Preisack, R Baildon, et al.
Pageof 50